Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05086016 · ClinicalTrials.gov registry record · NA
Growth Trial: Study of the Renata Minima Stent
A NA study of Pulmonary Artery Stenosis and Coarctation of the Aorta, sponsored by Renata Medical.
- Active
- Registry status
- NA
- Development phase
- 42
- Enrollment target
- 7
- Study locations
NCT05086016 is a NA study of Pulmonary Artery Stenosis and Coarctation of the Aorta that is active but no longer recruiting, run by Renata Medical. The registered enrollment target is 42 participants. The trial reports 7 study locations across 5 states.
The verdict
NCT05086016, a NA study of Pulmonary Artery Stenosis and Coarctation of the Aorta, is active but no longer recruiting, sponsored by Renata Medical.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 42 participants
- Enrollment target
- 7
- Study locations
Study Summary
The objective of the clinical investigation is to access clinical safety and effectiveness of the Minima Stent in neonates, infants, and young children requiring intervention for common congenital vascular stenosis (i.e., coarctation of the aorta and/or pulmonary artery stenosis) who are indicated for treatment.
Conditions Studied
Interventions
- DEVICE Catheterized Stenting
Study Locations (7)
California
- Children's Hospital Los Angeles - Los Angeles
- Cedars-Sinai Medical Center - Los Angeles
Ohio
- Cincinnati Children's Hospital - Cincinnati
- Nationwide Children's - Columbus
Massachusetts
- Boston Children's - Boston
Tennessee
- Le Bonheur Children's - Memphis
Washington
- Seattle Children's Hospital - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 42 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2028-03-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05086016
The ClinicalTrials.gov registry entry for NCT05086016 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Renata Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Pulmonary Artery Stenosis appearing as the primary indexed condition, and to 1 intervention - of which Catheterized Stenting is the first listed.
NCT05086016 reports 7 study locations spanning 5 distinct geographic areas - top geographies include California, Ohio, Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05086016 about?
NCT05086016 is a clinical study titled "Growth Trial: Study of the Renata Minima Stent". The objective of the clinical investigation is to access clinical safety and effectiveness of the Minima Stent in neonates, infants, and young children requiring intervention for common congenital vascular stenosis (i.e., coarctation of the aorta and/or pulmonary artery stenosis) who are indicated f...
What is the current status of trial NCT05086016?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 42 participants. The study started on 2021-01-14. Estimated completion is 2028-03-30.
What conditions does trial NCT05086016 study?
This clinical trial studies the following conditions: Pulmonary Artery Stenosis, Coarctation of the Aorta.
What interventions are being tested in trial NCT05086016?
The interventions under investigation include: Catheterized Stenting (DEVICE).
Who is sponsoring clinical trial NCT05086016?
This trial is sponsored by Renata Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05086016 being conducted?
This trial has 7 study locations across California, Massachusetts, Ohio, Tennessee, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pulmonary Artery Stenosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.